Liver cancer (primary and metastatic)

This small study will test a new device that uses heat to destroy liver tumors in 20 people who cannot have surgery. The main goal is to see if the device is safe and how well it works at shrinking tumors after one month. Researchers will also check how the treatment affects the …

This study tests a new treatment called EBNK-001, made from donor immune cells (natural killer cells), in people with advanced solid tumors that have not responded to standard therapies. Participants receive the cells after chemotherapy to prepare the body, along with low-dose in…

Researchers are studying whether a digital management platform can help diagnose liver cancer at an earlier stage in people with chronic liver disease. The study enrolls adults aged 18 to 75 with conditions such as chronic hepatitis B. The platform tracks patients and guides stan…

This study will collect data from 2,000 patients in the Netherlands and France who are receiving standard, minimally invasive cancer treatments like tumor ablation or catheter-based therapies for liver, lung, kidney, or bone cancers. During these procedures, a special CT scanner …

This study is gathering information from 800 people with liver cancer to track their diagnosis, treatments, and long-term health. The goal is to create a detailed database that helps doctors see what works best in real-world care. Participants must be 18 or older and treated at T…

This observational study follows 2000 adults with liver tumors who need surgery but have too little healthy liver left. Doctors use various techniques to make the liver grow before surgery. The study simply watches what happens in real practice—it does not test any new drug or tr…

This study tests a new type of CT scan used during procedures to treat liver and kidney cancers. About 30 adults with tumors larger than 1.5 cm will be enrolled. The goal is to see if the scan provides clearer images and helps doctors guide treatments more accurately.